The White House stood behind a declaration from a group of scientists advocating for a herd immunity approach to managing COVID-19, The New York Times reports.
Uncategorized
Seven observations and predictions related to physician practice ownership in 2020:
Madison, Wis.-based Exact Sciences introduced the Oncotype MAP Pan-Cancer Tissue test for patients with advanced, metastatic, refractory or recurrent cancer, according to an Oct. 12 press release.
At this point in the COVID-19 pandemic, testing, staffing and burnout are top of mind for ASC leaders.
Three notable updates on COVID-19 for ASC leaders to know:
On Oct. 12, Johnson & Johnson temporarily paused its COVID-19 vaccine candidate clinical trials after a participant developed an unexplained illness.
While largely isolated from initial and subsequent COVID-19 responses, ASCs have to ensure they have a comprehensive infection prevention plan to reduce the risk of viral transmission and continue elective procedures.
Researchers at Australia's national science agency, CSIRO, found evidence that the virus that causes COVID-19 can survive on common surfaces for up to 28 days, according to Technology Networks.
Here's what six otolaryngoloists told Becker's ASC Review about their outlook on the field over the next one to two years:
A woman lost hearing in one ear after having a mild COVID-19 infection, according to an Oct. 12 CNN report.
